Current research status of TOP2A gene with response to anthracycline-based chemotherapeutic agents in breast cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 127-129, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-384212
ABSTRACT
Anthracycline-based chemotherapeutic agents were extensively applied to the treatment of breast cancer. The relation of its response to TOP2A gene was proved by a number of clinical studies demonstrating that patients with both HER2 gene amplification and TOP2A gene aberration have a favored outcome,but a consensus was not yet achieved.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS